Pfizer Profile

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:3em;padding-top: 25px;;'>PFE</div>

Performance

12 / 100

Odds of Distress

Equity ratings for Pfizer are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 22, 2019 and ending today January 20, 2020. Click here to learn more.

Pfizer Profile

Upcoming quarterly earning report is expected on January 28, 2020. The stock experiences above average trading activities. Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in USA and is traded on BATS Exchange. It employs 92400 people. more on Pfizer
Pfizer Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Pfizer SEC Filings
Pfizer SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NamePfizer
ChairmanIan ReadView All
Thematic Classifications
Active investing themes Pfizer currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Pfizer.
Piotroski F Score
Academic score to determine the current strength of Pfizer financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
Pfizer ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: AA-Very Strong
Profitability
Few selected profitability drivers of Pfizer representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Pfizer (PFE) is traded on BATS Exchange in USA. It is located in 235 East 42nd Street, New York, NY 10017, United States and employs 92,400 people. Pfizer is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 202.66 B. Pfizer runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 5.53 B outstanding shares of which 57.14 M shares are at this time shorted by investors with about 3.25 days to cover shorted positions. PFIZER INC has about 12.99 B in cash with 4.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.35.
Check Pfizer Probability Of Bankruptcy

Ownership Allocation (%)

Pfizer Target Price Odds Analysis

Odds Below 40.51HorizonTargetOdds Above 40.51
98.04%30 days 40.51 1.92%
Based on normal probability distribution, the odds of Pfizer to move above current price in 30 days from now is about 1.92 (This Pfizer probability density function shows the probability of Pfizer Stock to fall within a particular range of prices over 30 days) .

Pfizer Top Holders

Pfizer Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Pfizer Against Markets

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Pfizer Upcoming and Recent Events

Pfizer Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportJanuary 28, 2020
Next Earnings ReportMay 5, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndJanuary 28, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Pfizer Corporate Filings

Pfizer SEC Reporting

Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Unclassified Corporate Event
Submission of Matters to a Vote of Security Holders
Entry into a Material Definitive Agreement

Pfizer Distributions to stockholders

Pfizer Corporate Directors

Helen Hobbs Independent Director
Shantanu Narayen Independent Director
James Smith Independent Director
Please also check Your Equity Center. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Company logos by clearbit